CA2194961A1 - Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof - Google Patents

Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof

Info

Publication number
CA2194961A1
CA2194961A1 CA002194961A CA2194961A CA2194961A1 CA 2194961 A1 CA2194961 A1 CA 2194961A1 CA 002194961 A CA002194961 A CA 002194961A CA 2194961 A CA2194961 A CA 2194961A CA 2194961 A1 CA2194961 A1 CA 2194961A1
Authority
CA
Canada
Prior art keywords
gas
oxygen
supersaturated
water
delivery system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002194961A
Other languages
French (fr)
Inventor
James Richard Spears
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23044845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2194961(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2194961A1 publication Critical patent/CA2194961A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21CPRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
    • D21C9/00After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters ; Treatment of dilute or dewatered pulp or process improvement taking place after obtaining the raw cellulosic material and not provided for elsewhere
    • D21C9/10Bleaching ; Apparatus therefor
    • D21C9/147Bleaching ; Apparatus therefor with oxygen or its allotropic modifications
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/54Mixing with gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698Blood oxygenators with or without heat-exchangers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32Oxygenators without membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/20Mixing gases with liquids
    • B01F23/23Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
    • B01F23/2319Methods of introducing gases into liquid media
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/20Mixing gases with liquids
    • B01F23/23Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
    • B01F23/237Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids characterised by the physical or chemical properties of gases or vapours introduced in the liquid media
    • B01F23/2376Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids characterised by the physical or chemical properties of gases or vapours introduced in the liquid media characterised by the gas being introduced
    • B01F23/23761Aerating, i.e. introducing oxygen containing gas in liquids
    • B01F23/237612Oxygen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/20Mixing gases with liquids
    • B01F23/29Mixing systems, i.e. flow charts or diagrams
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40Mixing liquids with liquids; Emulsifying
    • B01F23/45Mixing liquids with liquids; Emulsifying using flow mixing
    • B01F23/454Mixing liquids with liquids; Emulsifying using flow mixing by injecting a mixture of liquid and gas
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/04Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B13/00Oxygen; Ozone; Oxides or hydroxides in general
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B13/00Oxygen; Ozone; Oxides or hydroxides in general
    • C01B13/02Preparation of oxygen
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B5/00Water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1678Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes intracorporal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0057Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/0476Oxygenated solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/2202Mixing compositions or mixers in the medical or veterinary field
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/305Treatment of water, waste water or sewage
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/45Mixing in metallurgical processes of ferrous or non-ferrous materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/47Mixing of ingredients for making paper pulp, e.g. wood fibres or wood pulp
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/20Mixing gases with liquids
    • B01F23/23Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/20Mixing gases with liquids
    • B01F23/23Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
    • B01F23/237Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids characterised by the physical or chemical properties of gases or vapours introduced in the liquid media
    • B01F23/2376Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids characterised by the physical or chemical properties of gases or vapours introduced in the liquid media characterised by the gas being introduced
    • B01F23/23762Carbon dioxide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/818Aeration or oxygen transfer technique

Abstract

A method of injecting gas-supersaturated fluid (14) as a bubble-free effluent (18) from a delivery system into a relatively low pressure, gas-depleted environment without cavitation or bubble formation. The method includes the steps of eliminating (12) cavitation nuclei from within the delivery system, compressing (16) a liquid and a gas at a high partial pressure to form a gas-supersaturated liquid, and ejecting (18) the gas-supersaturated liquid through the delivery system into the environment without associated cavitation formation in the effluent.

Description

W096/01593 2 1 9 4 9 6 1 r~ ll~
.

METEIOD FOR DELIVERING
A GAS-SUPERSATURATED FLUID TO A
GAS-DEPLETED Sl~E AND USE THEREOF

TechnicaLField This invention relates to a method for deliv-ering a gas-supersaturated fluid from a high pressure environment to a gas-depleted site at a lower pressure without the ; -~;RtP onset of cavitation or hllhhl;n~

B~l~ ..1 Art The maximum concentration of gas achievable in a liquid ordinarily is governed by ~enry's Law. At ambient pressure, the relatively low solubility of many gaseBl such as oxygen or nitrogen, within a liquid such as water produces a low ~n~Pn~rRti~n of the gas in the li~uid. ~owever, there are many applications wherein it would be advantageous to employ a gas concentration within the liquid which greatly exceeds its solubility at ambient pressure. Compression of a gas~liquid mixture at a high pressure can be used to achieve a high dissolved gas uuLlu_-LLLation, but disturbance of a gas-supersaturated liquid by attempts to eject it into a 1 bar environment from a high pressure reservoir ordinari-ly results in cavitation inception at or near the exit port. The rapid evolution of bubbles produced at the exit port vents much o~ the gas from the liguid, 80 that a high degree of gas-supersaturation no longer exists in the liquid at ambient pressure, outside the high pres-sure vessel. In addition, the presence of bubbles in the effluent impedes the flow of the effluent beyond the exit port.

W096/01593 ~ 1 9 4 ~ 6 T PCT~S95/07991 In my co-~nding application Serial No.
152,589, filed November 15, 1993, I described a method for stabilization of a stream of oxygen-supersaturated water which permitted ejection of the stream from a high pressure vessel into a 1 bar environment without ca~ita-tion inception in the ~ffl ll~nt at or near the exit port~s). An effluent of water c~nt~inlng oxygen at a concentration on the order of 4 cc oxygen/g of injec-tate, representing a partial pressure of approximately 140 bar of the dissolved gas, can be ejected from a high pressure vessel into a 1 bar liquid environment with complete absence of cavitation inception in the ejected stream. In air at 1 bar, cavitation inception is delayed until breakup of the ejected stream into drop-lets.

The complete absence of cavitation inceptionin water supersaturated with oxygen at a high concentra-tion permits its in vivo infusion into either venous or arterial blood for the purpose of increasing the oxygen concentration of blood without incurring the f~rr-ti of bubbles which would otherwise occlude capillaries.

In addition to this application as previously described, a wide variety of other applications would benefit from ejection of a gas-supersaturated li4uid from a high pressure r~eservoir to ambient pressure in a manner which is unassociated with cavitation inception at or near the exit port. For example, organic material and plant waste stream5, e.g., paper mills and chemical plants, often re4uire an increase in dissolved oxygen content before the discharge of such waste streams in a body of water. U.S. Patent No. 4,965,022 also recogniz-es that a similar need may also occur at I ~c~p~l waste 2 1 ~ 4 9 6 1 . ~

~ -3-treatment plants. Also noted therein iB that fish farmg require increased dissolved oxygen levels to satisfy the needs of high density aquaculture. Other applications are disclosed in my ~.S. Patent No. 5,261,875.

U.S. Patent No. 4,664,680 discloses enriching the oxygen content of water. That reference discloses that a number of conventional apparatus types can be used for rnntinllmlcly rnnt8~-t;n~ liquid and oxygen-~nnt~in;n~ ga8 gtreams to effect oxygen absorption. To avoid premature liberation of dissolved oxygen before it is incorporated within the bulk of matter to be enriched in oxygen content, pr~cc~r;7~hl~ ~nnf;n~d flow passage-ways are used.

Other oxygen saturation devices are disclosed in U.S. Patent Nos. 4,874,509; and 4,973,558. These and other ~pFrn~ C leave unsolved the need to infuse gas enriched fluid enln~;nnq from a high pressure reservoir toward a reaction site at a lower pressure without cavitation or bubble formation in the effluent at or near the exit port.

~ v of the Ll"

A method is described for ejection of gas-supersaturated liquids from a high pressure reservoir to a relatively low pressure environment, including ambient pressure, which permits the use of the gas-~u~eL~LuL~t-ed liguid at the lower pressure without immediate cavitation inception. Cavitation nuclei in the liquid are removed by compression in a high pressure reservoir.
The use of suitable channels at the distal end of the system for delivery of the gas-supersaturated liquid, 219~961 PCT/US9 5 J 079 ~ l FEB 1996 along with elimination of cavitation nuclei along the inner surface of the rh~nn~l c, allows ejection of the liquid into a relatively low pressure environment without cavitation inception at or near the exit port.

Thus, an important aspect of the invention described herein is the use of small capillary channel~
at the distal end of the delivery system, along with initial hydrostatic compression of liquid in the range of 0.5 to 1.0 kbar to remove cavitation nuclei along the inner surface of the ~h~nnPl~ Cavitation nuclei and bubbles in the liquid are removed in the high pressure reservoir by either hydrostatic compression or compres-sion from a source of gas m~;ntiq;n~d at a pressure which would provide the desired concentration of gas in the liquid. Hydrostatic compre~ion between 0.5 and 1.0 kbar rapidly removes cavitation nuclei and bubbles in the liquid, but much lower pressures from a gas source are as effective, although requiring longer periods of time. When a gas source is used to both pressurize the liquid and achieve a desired gas concentration in the liquid, the~range of gas pressure would typically be in the 10 bar to 150 bar range.

As a result of the lack of cavitation incep-tion at or near the exit port, a stream of gas-supersat-urated liquid can be used to enrich a gas-deprived liquid with gas outside the high pressure reservoir simply by convection of the gas-supersaturated effluent with the gas-deprived liquid at ambient pressure.
Enrichment of a gas-deprived liquid with gas by diffu-sion from Ehe gas phase to the liquid is, by contrast, an extremely slow process. The lack of bubbles in the effluent additionally permits unimpeded ejection into AMENDEo SHEET

WO96/01~93 2 1 q4~ 1 r~~

_5_ the gas-deprived liquid. When the gas-Eupersaturated liquid is ejected in an air environment, the lack of cavitation inception at or near the exit port permits the use of the effluent in a manner similar to the same liquid which is not supersaturated with gas, i.e., the ejected stream remains intact until breakup into drop-lets as would ordinarily occur, rather than ~;~;ntegra-tion into a diffuse spray near the exit port from rapid growth of gas nuclei.

o Detailed D~a~ liul, of the r~f~ d ~d Best Modes For Carryin~ Out The L~

I now describe a ';f;rat;on of my earlier work, along with representative examples of practical applications of the method.

lS In order to ini~iate flow of oxygen-supersatu-rated water through capillary channels, such as silica tubings, it had been necessary to use an internal diameter at the exit port on the order of lO microns or less. ~owever, it has been discovered that flow of gas-supersaturated water can resume or continue through the larger proximal portion of the capillary tubing, once cavitation nuclei have been ~l;m;n~tPd from a channel along its entire length. ~li m; n~t; nn may be achieved, for example, by application of hydrostatic pressure.

As the internal diameter of the tubing in-creases, the maximum oxygen concentration which can be perfused through its length into a l bar aqueous medium without cavitation inception is reduced. For example, the maximum oxygen cu~c~L~L~tion which can be used in this manner for a lO0 micron internal diameter silica 2 9~ PCT/US9 5 / 0 7 9 9 ~YEAIUS~Zl FEB 199~

, .

tubing is approximately 1;5 cc oxygen/g, while that for a 25 micron tubing is approximately 3 cc oxygen/g.
Thus, larger bore capillary tubings can be used to deliver an effluent free of bubble formation, once cavitation nuclei are ~lim;n~ted~

Accordingly, there has been discovered an inverse relationship between the tubing ;n~rn~l diame-ter and the maximum oxygen concentration allowable.
Channels as large as 1 mm or greater can probably be used, but the maximum oxygen concentration which could be achieved without bubble production in the effluent would be less than that for the 100 micron tubing.

F, 't~ M Procedure A double-ended, high pressure vessel (Leco, Tem-Press Div.) having a honed cylindrical cavity with a 30 cc capacity was filled with 5 g ~ dextrose in water, equilibrated with oxygen at 800 psi. The oxygen-supersaturated fluid was transferred at 800 psi from a 300 cc capacity Parr bomb after equilibration overnight.
The Leco vessel 10 was isolated from the Parr bomb 16, and a piston, positioned at the proximal end of the Leco vessel 10 and sealed with O-rings, was driven against the oxygen-supersaturated fluid at approximately 0.7 kbar hydrostatic pressure from a hydraulic compressor.

The fluid was delivered through, for example, a 100 micron internal diameter/363 micron outer diameter fused silica tubing ~Polymicro Technologies) which had been tapered to 7 microns with a propane torch. After several minutes of hydrostatic compression to remove cavitation nuclei and determination that no bubbles appeared in the effluent as confirmed by use of argon-AMENDED SIIEET

~iq4~6~ PCT~US3 5 / o 7g g ~ IPEA/U~ 21 F E B 1996 ion laser illumination of fluorescein dye in the fluid, the silica tubing was cleaved several millimeters proximal to the tapered section. The internal diameter at the distal end of the tubing then was 100 microns.

~o cavitation inception occurred over a period of many hours, including refilling of the Leco vessel lO
from the Parr bomb 16 on multIple occasions. Even when the pressure in the Leco vessel 10 was allowed to fall to 1 bar, no bubbles in the effluent, containing 1.3 to 2.0 cc oxygen/g, were noted. When a second 100 micron silica tubing c~nt~;ning cavitation nuclei was placed in parallel with the first tubing, a prominent stream of bubbles was ejected from the second tubing, and no bubbles were noted in the first tubing. However, after use of a tapered distal end and transient hydrostatic pressure to 0.7 kbar, no bubbles were noted in the second tubing after cleavage of the tapered tip so that the internal diameter at the distal end was 100 microns.

In a preferred system, a hydraulic compressor is used to apply 0.5 to 1.~ kbar liquid water pressure to eliminate cavitation nuclei on the inner surface of ~h~nn~ , such as those ~abricated from multibore silica tubing, at the distal end of the delivery system. The liquid can either be either gas-depleted or gas en-riched Elimination of cavitation nuclei in the bulk gas-supersaturated liquid can be achieved simply by compression with gas at the desired partial pressure of the gas. Thus, when initiating flow through the silica tubing, high pressure liquid from the hydraulic compres-sor is used first, and subsequent flow of gas-supersatu-rated liquid would be delivered from a reservoir under pressure from gas tank.

AMENDED SHEET
; ~ .

2 1 ~
~ PCT/US9 5 / 0 7 9 9 1 IPE.WS 21 FE3 l996 When 02 gas compresse~ water before it is supersaturated, the combination of the gas pressure dissolving cavitation nuclei in the water and sufficient standing without excessive agitation (freestanding bubbles are inherently unstable-either they grow and rise to the surface or dissolve, although cavitation nuclei on the surfaces of the ~nntA;n~r or associated with motes may not disappear) eliminates bubbles.
Thereforet when gas-supersaturated water flows from the vessel pressurized from the 02 tank, no bubbles in the effluent are noted. If an occasional bubble or a cavitation nucleus a~ociated with a crevice in a mote flows through the tubing at the distal end of the delivery system 18, the stability of the effluent is unaffected. Very likely, when a bubble in the bulk liquid passes through the tubing, a thing film of liquid separates the bubble from the surface of the tubing, - thereby inhibiting the formation of a cavitation nucle-us. sy contrast, if cavitation nuclei are present on -the i~ner surface of the tubing, they generate rapid growth of bubbles cnn~;nnnusly n the effluent.

The advantages inherent in the use of an 02 gas source as the driving pressure for delivery of the 02-supersaturated fluid include the fact that only one hydraulic compressor is needed to "prepare" the catheter for use. The hydraulic compressor would very likely then no longer be needed. The volume of flow can be ad~usted by simply using the appropriate number of ~nn~ for a given i.d. The gag source would simulta-neously provide the partial pressure required to achievea de~ired concentration of gas in the water and the driving pressure for delivery of the ga~-supersaturated water through the channels at the distal end of the AMENDED SHEET
3 2 1 ~ 1 P~
.

_ g _ delivery system. The gas pressure used for this dual purpose would be on the order of 150 to 2000 psi.

Alternatively, a hydraulic u~ UL- is used to drive gas-supersaturated liquid through channels at the distal end of the delivery system. In order to m-;nt~;n a relatively constant pressure, either two reciprocating hydraulic compressors would be used or a E~ff;riPnt1y large reservoir would be interposed between the compressor and the channels, such that the pressure drop in the reservoir occurring during refilling of a single compressor is not excessive.

A simple approach to achieve a high hydrostat-ic pressure, on the order oi 0.5 to 1.0 kbar, within capillary channels to eliminate cavitation nuclei is to taper the distal end to a small diameter, on the order of ~ 20 microns, prior to application of the pressure.
~ltr~n~t;vely, relatively gas-depleted liquid can be perfused through larger channels at the same driving pressure; although a pressure drop at the distal end of a o the channels reduces the degree of hydrostatic compres-sion at this ~oc at; rn, the relative lack of gas in the liquid helps to dissolve cavitation nuclei at the lower pressure. The gas-supersaturated water at 1.5 to 2.0 cc oxygen/g can then be delivered through the non-tapered 2~ distal end into water without cavitation inception.
Once cavitation nuclei are ~l;m;n~ted, flow of oxygen supersaturated water through the 100 micron tubing into water can be achieved without bubble fnrm-t;rn in the effluent. The pressure in the high pressure vessel can then be lowered to 1 bar for many hours. With the ~ distal end of the tubing stored in ordinary tap water overnight, flow of an oxygen-superEaturated water, after Wo96/01593 2 ~ ~4 q ~ ~ pcTNssslo799l transient compression to 0.5 to 1 kbar, can be resumed without cavitation inception in the free stream.

Other ways may be used to ~l;m;n~t~ cavitation nuclei tlll~uylwuL the length of the tubing. Temporarily capping the distal end of the channels to allow full hydrostatic pressure to be applied to the end of ~the channels prior to ejection ~after removing the cap)~is effective.

~1 t~rn~t; vely,.a scavenger of the gas may be deployed in the liquid within the tubing, prior to flow of the gas-supersaturated liquid. Examples of the latter approach for removing oxygen-~nnt~;ning gas nuclei along the surface of the channels include a sodium sulfite soluti.on or a solution of deoxyhemo-globin. Either substance would bind oxygen and removethe gas nuclei.

Electrochemical reduction of oxygen in gas nuclei within, for example, a metal tubing may be used at the distal end of the system for delivery of oxygen-supersaturated water to eliminate the nuclei_ :~

Although ~rr~ i rat inn of a strong vacuum orheating the liquid within the tubing to a high tempera-ture might be used to remove cavitation nuclei along the inner surface of the channels, hydrostatic compression of the liquid (particularly a degassed one if necessary) is preferable.

~ here are several advantages in the use of channels having an i.nternal diameter larger than 10 microns: a much fewer number of channels are necessary W096/01~93 2 ~ ~4~ 6 ~

to deliver an equivalent flow; ~ te filtration of the gas-supersaturated liquid to prevent orr~ ;on of the channels iB much simpler to achieve; and the flow rate and velocity can be adjusted more easily by use of channels or tubings having a suitable length.

For example, a 30 micron internal diameter fused silica tubing (Polymicro Technology), approximate-ly 3 feet in length, will result in a flow velocity of approximately 200 cm/sec and a flow rate of approximate-ly 0.09 cc/min, when oxygen-su~eL~dLuL~ted 5 g~ dextrose in water ~prr~Y;r-tely 3,cc oxygen/g) is pressurized to 0.7 kbar and delivered through the tubing into blood at physiologic pressure. Xigher flow velocities may result in hemolysis, ao that use of the appropriate length of the tubing is helpful in adjustment of the velocity to an appropriately low level. By use of a bundle of 30 micron ;nt~rn~l diameter tubings, along with adjustment of the driving pressure between 1 bar to 1 kbar, after initial hydrostatic compression to 0.5 to 1 kbar, the overall ~10w rate can be varied to provide the desired rate of oxygen delivery.

While silica or glass capillary tubing is dis-closed, channels may also be defined within quartz, a metal, hollow carbon fibers, a ceramic, sapphire, or diamond.

A8 described in my copending application Serial No. 152,589, filed November 15, 1993, delivery of an oxygen-supersaturated physiologic solution into a vein or a right heart chamber can be used for either partial or complete support of systemic oxygenation of patients. Intra-arterial delivery of the fluid can be W096/01s93 2 1 9 ~ 9 6 1- PCT~S95/07991 used to achieve blood oxygen tensions much higher than that achievable by breathing oxygen to improve local oxygen delivery to hypoxic or ~schemic tissues.

For example, I have been able to oxygenate blood in vitro in the following manner. Venous blood was exposed to nitrogen to lower the oxygen tension to very low levels, on the order of ~ 20 mm Hg. Aliquot parts of 20 cc were placed in a plastic beaker and covered with Parafilm. One section of the wall of the beaker was replaced wilh a thin plastic film, so that an ultrasonic transducer could be positioned against the film, with an ultrasonic gel used as a coupling agent.
A two ~; ~irn~l image of the volume of blood was r~tinl1m1qly monitored. An electrode (Diamond General, Ann Arbor) was placed within the blood for cnntinlln--c monitoring of the partial pressure of oxygen.

One or more silica capillary tubings, having channel~s) ranging from 5 microns to l00 microns in internal diameter were used to deliver oxygen-supersatu-rated, cavitation nucleus-free 5 g~ dextrose in water from a high pressure ve5sel (Leco~ into the blood. The threshold partial pre~sure of oxygen at which multiple bubbles appeared by ultrasound was recorded. A mean partial pressure of oxygen of 800 to 900 mm Hg was achieved before the on~et of bubble formation in approx-imately 20 runs.

Thus, the oxygen tensions achievable in blood are higher than l bar. Considering that, in a hyperbar-ic oxygen chamber, air is compressed rather than pure oxygen, the partial pressure of oxygen achievable in such chambers pressurized to 2-3 bar are on the order of Wo96/01593 2 1 9 4 9 6 ~ PcT~sg5~0799~
.

only 350 to 650 mm Hg. In addition, the high oxygen tensions in the compressed gas result in lung toxicity upon exposure for more than a few hours. Infusion of oxygen-supersaturated phy5iologic solutions into arteri-al blood, in contrast to the use of a hyperbaric cham-ber, can be used to achieve higher oxygen tension levels and do so for a much longer period of time. Treatment of local tissue hypoxia or i~rh~m;~ by this approach can be achieved by pl~, t of a catheter within the lo arterial blood supply of the target tissue.

Table A discloses examples of and derivations from experimental observations made during the practice of the present invention. Wh-n an OL gas source is used to provide the driving pLe~uLe~ at 10 to 150 bar, the minimum length is reduced by a factor equal to the ratio of 0.7 kbar to the gas pressure.

21q49~
WO 96101593 PCTIUS9~107991 o ~
S o~ ~ I' ~ -- o o ~ ~ ~o o ooooooooooo -~,, a :

O O O O 0 1~1 ~ ~ ~ ~ O ~ ~
O ~
~ O

Z; ~ ~ . -Oc ~1 o r~ o g ~5 ~ Z

~ ~ o ~ ~O C -- ~ ~ CO O ~ ~
O 'r ~t t V~ ~ ~ , , ¢ ~

E~ ~ . c 2 - 8 ~ ~ ~ ~ ~ -- ~ ~ ~ ~ g ~ E - .

- O O 8 8 g g O O ~ 8 ~ . 8 . r : .

g V~ _ 5 o _ ~o O

; ~ ~
,~o Wo96101593 2 1 q 4 9 6 1 Other Uses .~ A. ~
Since oxygen is pal gn~tic, infusion of oxygen-supersaturated solutions into blood would be expected to enhance imaging of blood and oxygenated tissues by magnetic resonance imaging (MRI). That is, an oxygen-supersaturated solution would be expected to act as an MRI contrast agent.

B. Iovic~l . '. . ' If oxygen-supersaturated physiologic solution or water were placed in contact with a body surface, ;nr~ ;ng skin and wounds, a marked increase in the rate of ~;ffnc;nn of oxygen into tissue would occur, since the partial pl~s~u~ of the gas could be made to be as high as apprnY;r-t~ly 140 bar.

In addition, as water diffuses across a body surface, oxygen in the gas-supersaturated fluid would be transported, thereby ~nh~n~;ng the rate of diffusion of the gas into tissue.

zo In wounds which are ischemic, the improved oxygen levels in tissue would increase the rate of healing. For a large surface area to mass ratio, such as in young infants or n~nn~t~c, contact of most of the surface area of the body (~r11~;ng the head) with oxygen-supersaturated fluid may result in a significant increase in blood oxygen tension levels, when oxygena-tion by v~nt; 1 ~t i on alone is associated with systemic hypoxemia.

Wo 96/01593 2 1 9 4 q 6 1 -16- PCr~7SsS/079~l Ventilation with oxygen-supersaturated physio-logic soll-t;c nf7 could be used to support systemic oxygenation in patients with respiratory insufficiency. r Inflation of atelectatic regions of the lung with 5 oxygen-~ju~ dLu~ c ted liquids would be more effective than air or 02 gas in ~rAnr.7ing alveoli and more effec-tive in ~nhAnn;ng oxygen diffusion to p--l y capil-laries. In addition, ;n~lAt;nn of the lung with the liquid would simultane~ously be useful to remove unwanted lO lung exudates.

Topical application of oxygen-supersaturated solutions to wounds, in addition to relieving tissue hypoxia, could be used to clean, debride, and sterilize such tissues. Hydrogen peroxide sc7lutinnc are used 15 currently for these purposes, but cells within granula-tion tissue may be damaged along with bacteria by peroxide solutions. ln contrast, a hyperbaric oxygen solution would be tox.ic to bacteria and b~n~;~i Al to tissue within the wound.

2 o C Industrial ~?.
The ability to inject a gas-supersaturated fluid into a relatively low pressure environment without immediate cavitation ;n~.opt;nn would find utility in many industrial applications. The following applica-25 tions are representative examples.

1. Fire r . ~ . When cavitation=free, gas-supersaturated water i.s ejected at a high velocity fromthe distal end of a t:ube, gas nucleation occurs after breakup of the stream into droplets because of the 30 inherent tensile strength of water. If an inert gas, such as nitrogen, carbon dioxide, or argon i8 dissolved WO96/01~93 2 1 9 4 9 6 1 rcT~5s~/o7ssl in water at a supersaturated concentration and com-pressed to remove cavitation nuclei, a stream of water rnntA;n;ng the gas under high pressure can be delivered into a 1 bar air or liquid environment without cavita-tion taking place near the exit port.

For example, nitrogen can be dissolved at a pressure of approximately 150 bar in water either before or after 0.5 to 1.0 kbar hydrostatic compression to remove cavitation nuclei. The stream of water that can lC be ejected from a suitable tubing preserves the metast-ability of the fluid by the absence of cavitation nuclei. Upon contact of the gas-supersaturated stream of water with solid surfaces, spnntAn~ous breakup into droplets occurs and the gas is released suddenly. A
similar result follows heating.

To extinguish a fire, the gas release will be b~n~fir;Al in at least 3 ways. The ~rAnRinn of the gas will aid the disperaion of~water over a broader volume;
~YrAnqinn of gas results in cooling; and the inert gas 2C will displace oxygen in the air. Although this method of extinguishing a fire would be expected to be more costly, it should make more efficient use of water and, more importantly, it should be more effective than the conventional use of water. Such b~nPf;tc are enhanced in draught-stricken areas and in other situations where there is difficulty in delivering enough extinguishing water to the ;nr~n~;Ary area.

I c~n~l~rt~ a test of this Arpl;r~t;on in the fnll~ -;n~ manner. A iet stream of water, delivered from a high pressure vessel at 0.7 kbar and having a velocity of approximately 2,000 cm/sec through a 10 micron i.d.

WO96/01593 ~ 1 q ~ q 6 I PCT~S95/07991 ~1 -la -silica tubing, was directed at the Elame of a laboratory propane torch. The flow rate of propane was adjusted so that the apex of the inner blue portion of the flame ro;nr;~d with the end of the metal collar. Starting with a distance of about 8 inches between the distal end of the silica tubing and the apex of the blue portion of the flame, the distance was reduced until the flame was either ~Yt;n~l;ch~d or the distance was less than 1 inch.

With no gas in the water, a mean distance of 2 to 3 inc_es was re~lired in 3 runs to extinguish the flame. In one run, the flame could not be extinguished.
In another, a distance of approximately 1 inch was re-~uired.

In contrast, when water was supersaturated with argon at 1700 psi (approximately 3 cc gas/g) and hydrostatically compre3r~ed to 0.8 kbar to eliminate cavitation nuclei, a mean distance oE approximately 4.5 to 5 inches was effective in ~h~l;ching the flame in each of 4 runs. The silica tip and flow conditions for these runs were identical to those without gas in the water.

Thus, it i5 clear that the use of water super-saturated with an inert gas, st~h;l; 7~d by hydrostatic compression and use oE the tapered silica tip, was far more effective than the use of water alone for extin-guishing the flame of the propane torch.

2. r .- and Carbonation of Bevera~es. Water used for human consumption undergoes multiple steps to ensure purity and lack of r~nt~;n~nts which could affect W096/01593 2 1 9 4 9 6t ~
.

either health or taste. One commonly used initial step is chemical treatment to oxidize rnnt~m;n~ntr.

Infusion of oxygen-supersaturated, cavitation-free water is a more efficient method of oxidation than the use of oxygen gas (since oxyg~n~t;nn of water by convection is more efficient that by diffusion), and would be DnntnY;r, in contrast t,o the use of peroxides.

Once water for the beverage has been purified, carbon dioxide is usually introduced prior to sealing it lo in a bottle or oan (or an undercover gasser may be used for cans). The gas is usually introduced under high pressure at a low temperature in order to increase its ~ dissolved concentration. The use o~ water supersaturat-ed with carbon dioxide and treated to remove all cavita-tion nuclei would allow the process of carbonation to be conducted at virtually any ambient room temperature, thereby obviating the need for cooling. If the inside walls of the cnnt~;n~rs were also free of significant cavitation nuclei, it should be possible to store the beverage at room temperature and to open the rnnt~;nrr at the higher than usual temperature without p.~ nPnt bubble evolution and without sirn;f;c~nt 1088 of the carbonation.

An interesting alternative to the use of carbon dioxide to provide effervescence in beverages is the use of oxygen, air, or nitrogen. The limited solubility of these gases ordinarily precludes their use for this purpose. However, by mixing water supersatu-rated with any of the gases with a syrup concentrate ; ~;~trly before consumption, a gas yield of the WO9~01593 21q4q6 1 -20-resultant beverage would be similar to that currently used in n~rhnn~ted beverages.

When oxygen or air is used ln this manner, the hyperbaric oxygen content in the beverage would help maintain sterility, and its consumption would be expect-ed to have a more favorable inhibitory effect on bacte-rial pathogens in the oral cavity compared to the use of carbon dioxide.

3. ~ . During the process of making lo steel, an oxygen "lance" is used to deliver oxvgen gas initially to the surface of the crude metal melt and subse~uently to deeper layers with the help of cooling water jets adjacent to the high velocity oxygen. The purpose of the oxygen treatment is to oxidize undesir-1~ able materials such as carbon and silicon. ~The frothymixture which is produced floats at the top of the melt and is poured off, leaving the purified molten steel.

The use of water supersaturated with oxygen would be expected to be more effective in penetrating the molten metal compared to the stream of oxygen gas.
The n~ t;nn process would therefore be more rapid and complete, resulting i.n a steel having superior yield characteristics and a more efficient method.
4. D~l;c..:r . Of Wood Pulo. Bleaching of wood 2~ pulp and its delignification re~uire oxygen which is introduced either as a gas or in the form of hydrogen peroxide. The use of oxygen supersaturated water would be a far more efficient means of oxygenation of the slurry rnnt~;n;ng the wood pulp, and higher levels of W096/01593 2 1 9 4 9 b ~ PCT~S9510799~

oxygen tension could be obtained ~ dL~d to the use of oxygen gas.

Following such treatment, the effluent would be less toxic compared to the use of hydrogen peroxide.
In ~;t;nn, the latter would be PYpe~tPd to be more expensive than the use of oxygen-~u~el~dLuLdted water.

S. W~ P Treatmfnt. All currently available methods of treatment of wastewater are based on some means of mixing air or oxygen gas with water and rely on the slow process of diffusion from the gas to the liquid phase for oxygenation of the wastewater.
Similarly, most methods for introducing oxygen into bioreactors, which are used to produce a byproduct such as a drug, rely on mixing oxygen gas with water within lS which organisms are suspended. The rate of oxygen consumption by some organisms is quite rapid, so that introducing oxygen sufficiently rapidly has inspired the design of many types of bioreactors.

The basic mass transfer steps (i.e. the steps 2C through which oxygen must pass) in moving from air (or oxygen-enriched air) to the reaction site in a biologi-cal species consist of: transport through the gas film inside the bubble; across the bubble-liquid interface;
through the liquid film around the bubble; across the 2~ well-mixed bulk liquid (broth); through the liguid film around the biological species; and finally transport within the species (e.g. cell, seed, microbial species) to the bio-reaction site. Each step offers a resistance to oxygen transfer. The rate-limiting step typically occurs at the air-liguid intPrf~p.

WO96101593 F~~ .5./,,l The use of oxygen ~u~eL~LuL~ted water would be far more rapid th.an currently available methods, since (as noted earlier) oxygenation by convection is significantly more rapid than by diffusion, and would allow fine control of the optimal partial pressure of oxygen within the bioreactor.

In the biotechnology field, the supply of oxygen to a growing biological species (aeration) in an aerobic bio-reactor is one of the most critical require-ments in biotechnology. Aeration is usually accom-plished by transferring oxygen from the air into the fluid surrounding the biological species from whence it is, in turn, transferred to the hjnlogir~l species itself. The rate at which oxygen is demanded by the biological species in a bio-reactor depends on the species, its concentration,~and on the cnn~ntratin~ of other nutrients in the surrounding fluid.

The main reason for the importance of aeration lies in the limited solubility of oxygen and water, a value which decreases in the presence of electrolytes and other solutes as temperature increases. A typical value for the soll~hility of oxygen (the equilibrium saturation concentration) and water in the presence of air at ~ sph~ric pressure at 25 C is about 0.008 g of oxygen per m3 (i.e. about 8 ppm).

In addition to each bio-reaction ~ ~ing oxygen at a different rate, there is a unique relation-ship for each between _he rate of reaction and the level of dissolved oxygen.

WO96/01593 2 1 q ~ q 6 1 ~ u~
~.

6. 0~. of Ponds, Lakes. Sfreams, e~ I Fisheries.
SwimminrPoolsandA~uniciDalDrinkin~Water. In order to promote .~ an aerobic environment in these bodies of water, oxygen within air is mixed within the water. As noted above, ~, 5 this process is inefficient because of the relatively 810w process of diffusion from the gas phase into the liguid.
!

Injection of air- or oxygen-supersaturated water into such bodies of water would not only be a far more efficient means of transfer of oxygen, but a high velocity stream of the ~as-supersaturated water would penetrate far more effectively into large bodies of water than either a gas or a gas/water mixture. The stream could be directed from a more superficial loca-tion to penetrate deep layers of water, in contrast tothe need to position a gas/water mixing apparatus or a bubble generator within deep layers of water.

7. Cleaninr Of Surfaces. Water jets are commonly employed to clean surfaces of factory floors, the exterior of b~ ingq, bridges, gas (e.g., air).

Supersaturated water would be expected to be more efficient, since the sudden P~r~nqi~n of the gas upon contact with the surface would provide an addition-al force ior removal of surface materials. Cavitation inception upon contact with the surface would act in a similar manner to the action of sandblasting, but would not, in contrast, pose an envi~, ~l concern.

8. Fn' Of ChemicalReactions. When a chemical reaction involves the use of a gas in a li~uid medium, the rate of reaction at ambient pressure will be WO96/01593 2 ~ q ~ 9 ~ ~ P~IIrJ~

enhanced by the use of a gas-supersatsurat~ed lir~uid. In addition, in exothermic reactions, wherein it is desir-able to avoid an excessive rise in temperature, the liquid carrying the gas at a supersaturated cullu~lLL~-tion could be used as ballast.

In;ection of water supersaturated with either oxygen or air into or onto an organic fuel for enhance-ment of combustion and control of t ,eL~LuLe represents one such example. Similarly, if liquid fuel is super-saturated with air or oxygen and cavitation nuclei havebeen removed within the delivery system rnnt~in;ng the gas-supersaturated fuel, combustion of the fuel upon its ejection from the high pressure vessel and upon ignition would be expected to proceed more rapidly than the use of the fuel alone. The high pressure of oxygen within the fuel, along with a broad surface area presented when the stream of iuel breaks up into droplets and subse-quently microscopic bubbles, would be responsible for the improved rate of combustion .

9. S~ . With the use of conventional ~n-- k;nr~ equipment, e.g., for recreational skiing, the ice particles are produced before ejection into the ai ~ ~. Therefore, the distance which the snow can be blown with air is limited. When air-supersaturated water is e~ected at a high velocity into ambient air, cavitation nuclei are formed after breakup of the stream into a fine mist. During expansion of gas, nuclei form during or after breaku!? of the stream into a mist, and the temperature of each droplet will fall as a result of L~r~nrl;nn of the gas.

WO96101~93 2 1 94 9 6 1 Strobe light photography at a 20 ns exposure (Xenon Corp.) under a light microscope has ~ LL~ted that each droplet of gas-supersaturated water is trans-formed into a bubble. If the temperature of the water is near O C at the time of ejection from a high pressure reservoir, the fall in temperature will convert each droplet into a particle of ice or snow.

Use of water at high pressure has the addi-tional advantage of depressing its freezing point. For example, at l kbar, the freezing point of water is approximately -11 C. Thus, the water could be ejected at a te~ el~LuLe even below O-C, and gas r~r~nRinn would cool the resultant ice particles to a yet lower tempera-ture. Ejection of a stream of water, supersaturated with air, into the c ~ e could be used to cover much greater distances than that achievable with conven-tional Rn( king ~r~ll; . Fewer machines would be required with this method to cover the same area with artificial snow, which would be a more efficient and, very likely, more - r~l meang of snowmaking.

10. Ol~er Uses The physical and chemical proper-ties of a liquid supersaturated with a gas differ fromeither that of the liquid or the gas. 9uch properties are too numerous to ~l~hr,r~tP, but include, in alphabet-ical order, the boiling point, chemical potential,compressibility, density, dielectric constant, enthalpy, free energy, heat capacity, magnetic susceptibility, specific heat, surface tension, thermal conductivity, and viscosity.

The ability to use a liquid supersaturated with a gas at a relatively low pLés~uLe is the basis of WO96/01593 2 1 q 4 q 6 ~ PCTNS95/07991 all applications of the invention. Accordingly, use of any physical or chemical,~Lv~LLy of gas-supersaturated liquids at a relative].y low pressure fPlls within the scope of the invention. - ~

Claims (19)

What Is Claimed Is:
1. A method of injecting gas-supersaturated fluids as a bubble-free effluent from a delivery system into a gas-depleted environment, comprising the steps of:
a. eliminating cavitation nuclei from within the delivery system;
b. compressing a liquid and a gas to form a gas-supersaturated liquid; and c. ejecting the gas-supersaturated liquid through the delivery system into the environment without associated cavitation formation in the effluent at or near the exit position.
2. The method of claim 1 wherein the nuclei in the delivery system are removed by hydrostatic compression with a liquid having a relatively low concentration of the nuclei.
3. The method of claim 1 wherein the nuclei in the delivery system are removed by hydrostatic compression with the gas-supersaturated effluent.
4. The method of claim 1 wherein the nuclei in the delivery system are removed by perfusion with a solution containing a scavenger of the nuclei.
5. The method of claim 1 wherein the nuclei in the delivery system are removed by capping the distal end of the delivery system and applying hydrostatic pressure.
6. The method of claim 1 wherein the gas is dissolved in the fluid at a high partial pressure of the gas prior to compression of the fluid.
7. The method of claim 1 wherein the hydrostatic pressure is varied over a 10 bar to 10 kbar range after transient application of a 0.3 to 1.0 kbar pressure.
8. The method of claim 1 wherein the delivery system includes channels each having an internal diameter in a range of 0.1 micron to 1 cm.
9. The method of claim 1 wherein the fluid is water.
10. The method of claim 1 wherein the gas is oxygen.
11. The method of claim 1 wherein the gas is an inert gas.
12. The method of claim 1 wherein the gas is air.
13. The method of claim 9 or 10 wherein the environment is blood.
14. The method of claims 9 or 10 or 12 wherein the environment is a bioreactor.
15. The method of claims 9 or 10 or 12 wherein the environment is wastewater.
16. The method of claims 9 or 10 or 12 wherein the environment is potable water.
17. The method of claims 9 or 10 or 12 wherein the environment is a fishery.
18. The method of claims 9 or 10 or 12 wherein the environment is a lake, pond, stream, swimming pool, or municipal water.
19. The method of claims 9 or 11 wherein the environment is a fire and materials undergoing combustion.
CA002194961A 1994-07-12 1995-06-26 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof Abandoned CA2194961A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/273,652 US5569180A (en) 1991-02-14 1994-07-12 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof
US273,652 1994-07-12

Publications (1)

Publication Number Publication Date
CA2194961A1 true CA2194961A1 (en) 1996-01-25

Family

ID=23044845

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002194961A Abandoned CA2194961A1 (en) 1994-07-12 1995-06-26 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof

Country Status (9)

Country Link
US (2) US5569180A (en)
EP (1) EP0767632B1 (en)
JP (1) JP3712729B2 (en)
AT (1) ATE227107T1 (en)
AU (1) AU685651B2 (en)
CA (1) CA2194961A1 (en)
DE (1) DE69528766T2 (en)
ES (1) ES2184804T3 (en)
WO (1) WO1996001593A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599296A (en) * 1991-02-14 1997-02-04 Wayne State University Apparatus and method of delivery of gas-supersaturated liquids
US5730935A (en) * 1984-07-12 1998-03-24 Wayne State University High pressure gas exchanger
US6344489B1 (en) * 1991-02-14 2002-02-05 Wayne State University Stabilized gas-enriched and gas-supersaturated liquids
USRE37379E1 (en) 1991-02-14 2001-09-18 Wayne State University High pressure gas exchanger
US6315942B1 (en) 1993-11-15 2001-11-13 Wayne State University System for delivery of gas-enriched fluids
US6607698B1 (en) * 1997-08-15 2003-08-19 Therox, Inc. Method for generalized extracorporeal support
US6312647B1 (en) 1994-12-09 2001-11-06 Wayne State University Method for enriching a fluid with oxygen
US6180059B1 (en) * 1995-06-05 2001-01-30 Therox, Inc. Method for the preparation and delivery of gas-enriched fluids
US6676900B1 (en) 1994-12-09 2004-01-13 Therox, Inc. Method for the preparation and delivery of gas-enriched fluids
US6082373A (en) * 1996-07-05 2000-07-04 Kabushiki Kaisha Toshiba Cleaning method
US5814125A (en) * 1997-03-18 1998-09-29 Praxair Technology, Inc. Method for introducing gas into a liquid
JP2001520575A (en) * 1997-04-16 2001-10-30 ウェイン ステイト ユニヴァーシティ System and apparatus for delivery of gas supersaturated fluid
US5971368A (en) 1997-10-29 1999-10-26 Fsi International, Inc. System to increase the quantity of dissolved gas in a liquid and to maintain the increased quantity of dissolved gas in the liquid until utilized
US6068773A (en) * 1998-05-01 2000-05-30 Sheaffer International Ltd. Single-cell wastewater reclamation and reuse system
US6176894B1 (en) 1998-06-17 2001-01-23 Praxair Technology, Inc. Supersonic coherent gas jet for providing gas into a liquid
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6394096B1 (en) 1998-07-15 2002-05-28 Corazon Technologies, Inc. Method and apparatus for treatment of cardiovascular tissue mineralization
US6063295A (en) * 1998-07-23 2000-05-16 Williams; Russell L. Apparatus and method to increase oxygen levels in livestock drinking water
US6602467B1 (en) 1998-07-24 2003-08-05 Therox, Inc. Apparatus and method for blood oxygenation
US6235641B1 (en) 1998-10-30 2001-05-22 Fsi International Inc. Method and system to control the concentration of dissolved gas in a liquid
US6238706B1 (en) 1999-05-06 2001-05-29 Grofish L.L.C. Method of stimulating growth in aquatic animals using growth hormones
US6406551B1 (en) 1999-05-14 2002-06-18 Fsi International, Inc. Method for treating a substrate with heat sensitive agents
US6274506B1 (en) 1999-05-14 2001-08-14 Fsi International, Inc. Apparatus and method for dispensing processing fluid toward a substrate surface
US6759008B1 (en) 1999-09-30 2004-07-06 Therox, Inc. Apparatus and method for blood oxygenation
US6890482B2 (en) 1999-09-30 2005-05-10 Therox, Inc. Apparatus for blood oxygenation
ATE344066T1 (en) 1999-09-30 2006-11-15 Therox Inc DEVICE FOR BLOOD OXYGENATION
US6387324B1 (en) 1999-09-30 2002-05-14 Therox, Inc. Apparatus and method for blood oxygenation
US20050150618A1 (en) * 2000-05-17 2005-07-14 Bijan Kazem Methods of processing lignocellulosic pulp with cavitation
KR20030038546A (en) * 2000-05-25 2003-05-16 리차드 에스 블로스맨 A hydrating system
US7008535B1 (en) 2000-08-04 2006-03-07 Wayne State University Apparatus for oxygenating wastewater
WO2002069711A1 (en) * 2001-03-02 2002-09-12 Neuron Therapeutics, Inc. Gene therapy for neurological tissues
US6582387B2 (en) * 2001-03-20 2003-06-24 Therox, Inc. System for enriching a bodily fluid with a gas
US6613280B2 (en) * 2001-03-20 2003-09-02 Therox, Inc. Disposable cartridge for producing gas-enriched fluids
FR2822713B1 (en) * 2001-04-02 2003-05-16 Air Liquide METHOD AND DEVICE FOR TREATING A FIRE IN AN AIRCRAFT COMPARTMENT
US20100151041A1 (en) * 2001-07-18 2010-06-17 Eckert C Edward Hypersaturated gas in liquid
US7288574B2 (en) * 2001-07-18 2007-10-30 Eckert C Edward Two-phase oxygenated solution and method of use
US20060030900A1 (en) * 2001-07-18 2006-02-09 Eckert C E Two-phase oxygenated solution and method of use
US20130041312A1 (en) * 2007-09-19 2013-02-14 C. Edward Eckert Using Aqueous Oxygenation to Improve Human Wellness
US20120156309A1 (en) * 2007-09-19 2012-06-21 Eckert C Edward Using Aqueous Oxygenation to Improve Animal Health & Wellness
US7771582B2 (en) * 2003-05-19 2010-08-10 Hydro Dnamics, Inc. Method and apparatus for conducting a chemical reaction in the presence of cavitation and an electrical current
US20050042129A1 (en) * 2003-08-22 2005-02-24 Bijan Kazem Method and apparatus for irradiating fluids
CN1305535C (en) * 2003-12-29 2007-03-21 邢军 Medical high oxygen liquid, human blood oxygenating method and its instrument
US9248415B2 (en) 2004-05-25 2016-02-02 Board Of Trustees Of The University Of Arkansas Systems and methods for maximizing dissolved gas concentration of a single species of gas from a mixture of multiple gases
US9340438B2 (en) 2004-05-25 2016-05-17 Board Of Trustees Of The University Of Arkansas Systems and methods for delivering dissolved gases into force-main and gravity sewers
US20120228396A1 (en) * 2004-05-25 2012-09-13 Gregory Scott Osborn System and Method for Optimizing the Dissolution of a Gas in a Liquid
WO2005115598A2 (en) 2004-05-25 2005-12-08 The Board Of Trustees Of The University Of Arkansas System and method for dissolving gases in liquids
US9315402B2 (en) 2004-05-25 2016-04-19 Board Of Trustees Of The University Of Arkansas Systems and methods for wastewater treatment
US20070003528A1 (en) * 2005-06-29 2007-01-04 Paul Consigny Intracoronary device and method of use thereof
US7682360B2 (en) * 2006-12-07 2010-03-23 Tyco Healthcare Group Lp Bipolar tissue debrider and method
US20090098017A1 (en) * 2007-10-16 2009-04-16 Board Of Regents, The University Of Texas System Nanoporous membrane exchanger
US8430968B2 (en) 2008-01-22 2013-04-30 Hydro Dynamics, Inc. Method of extracting starches and sugar from biological material using controlled cavitation
US8192384B2 (en) 2008-12-04 2012-06-05 Therox, Inc. System for enriching a bodily fluid with a gas having a dual-function power switch mechanism
US8636952B2 (en) 2008-12-04 2014-01-28 Therox, Inc. System for enriching a bodily fluid with a gas having a removable gas-enrichment device with an information recording element
US8246564B2 (en) 2008-12-04 2012-08-21 Therox, Inc. System for enriching a bodily fluid with a gas having automated priming capabilities
US8500104B2 (en) 2010-06-07 2013-08-06 James Richard Spears Pressurized liquid stream with dissolved gas
EP2663193B1 (en) 2011-01-14 2019-05-08 Children's Hospital Los Angeles Solution of carbon monoxide for treatment of disease, including sickle cell disease
CN103608065A (en) * 2011-04-19 2014-02-26 因维希德姆有限责任公司 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US20130079800A1 (en) * 2011-08-04 2013-03-28 C. Edward Eckert Method for debriding human tissue
US8888902B2 (en) * 2011-08-26 2014-11-18 Separation Design Group Llc Portable oxygen enrichment device and method of use
US10130800B2 (en) 2012-01-27 2018-11-20 Invisiderm, Llc Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
WO2013165473A1 (en) 2012-05-01 2013-11-07 Therox, Inc. System and method for bubble-free gas-enrichment of flowing liquid within a conduit
US9604863B2 (en) 2013-08-05 2017-03-28 P. K. Andy Hong Pressure cycling wastewater treatment apparatus
US10173030B2 (en) 2013-11-15 2019-01-08 Oakwood Healthcare, Inc. Catheter for infusion of a cardiovascular fluid
US10961488B2 (en) * 2015-04-15 2021-03-30 Board Of Trustees Of The University Of Arkansas Method for controlling the concentration of single and multiple dissolved gases in beverages
US10077418B2 (en) * 2015-04-15 2018-09-18 Board Of Trustees Of The University Of Arkansas Method for improved rate and control of beverage carbonation with automatic shut-off
US10479668B2 (en) 2016-11-08 2019-11-19 Pepsico, Inc. Ambient filling system and method
US10486115B2 (en) 2017-05-10 2019-11-26 Gaps Technology LLC. System and method for stably infusing gas into liquid, and for delivering the stabilized gas-infused liquid into another liquid
US11129848B2 (en) 2017-08-08 2021-09-28 Perricone Hydrogen Water Company, Llc Medication enhancement using hydrogen
US20190046561A1 (en) 2017-08-08 2019-02-14 Perricone Hydrogen Water Company, Llc Barriers for glass and other materials
EP3944735A4 (en) * 2019-04-01 2023-01-25 Judith Boston Treatment of ischemic conditions, hypoxic conditions, conditions related to a hypoxia-induction factor
US10561682B1 (en) * 2019-04-01 2020-02-18 Judith Boston Treatment of ischemic conditions, hypoxic conditions, conditions related to a hypoxia-induction factor, or conditions related to reactive oxygen species with oxygen-containing liquids
US11123365B2 (en) 2019-11-18 2021-09-21 Perricone Hydrogen Water Company, Llc Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1940341A (en) * 1928-08-14 1933-12-19 Krupp Ag Treating iron baths
DE1033689B (en) * 1957-03-20 1958-07-10 Linde Eismasch Ag Process for evaporation of hydrocarbon-containing liquid oxygen and device for carrying out the process
US3459565A (en) * 1967-03-13 1969-08-05 Dow Chemical Co Foamable granule product with method of preparation and molding
US3721231A (en) * 1971-02-01 1973-03-20 Becton Dickinson Co Catheter for high pressure injections
US3963503A (en) * 1972-07-05 1976-06-15 The Regents Of The University Of California Method of making glass products, novel glass mix and novel glass product
US3972721A (en) * 1974-03-01 1976-08-03 Ppg Industries, Inc. Thermally stable and crush resistant microporous glass catalyst supports and methods of making
US4075025A (en) * 1976-05-10 1978-02-21 Pittsburgh Corning Corporation Method of forming a potassium aluminoborosilicate frit
US4122858A (en) * 1977-03-23 1978-10-31 Peter Schiff Adapter for intra-aortic balloons and the like
US4323420A (en) * 1978-07-17 1982-04-06 The United States Of America As Represented By The United States Department Of Energy Process for manufacture of inertial confinement fusion targets and resulting product
US4303432A (en) * 1978-08-28 1981-12-01 Torobin Leonard B Method for compressing gaseous materials in a contained volume
CH637355A5 (en) * 1978-10-06 1983-07-29 Millcell Ag FOAM GLASS GRANULES AND METHOD FOR THE PRODUCTION THEREOF.
CH637606A5 (en) * 1978-11-30 1983-08-15 Millcell Ag FOAM GLASS GRANULES AND PROCESS FOR PRODUCTION.
US4372491A (en) * 1979-02-26 1983-02-08 Fishgal Semyon I Fuel-feed system
US4285977A (en) * 1979-10-10 1981-08-25 General Foods Corporation Process for preparing carbonated liquids
CA1148570A (en) * 1980-03-17 1983-06-21 Isamu Iwami Foamable glass composition and glass foam
US4657532A (en) * 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
US4385635A (en) * 1980-04-25 1983-05-31 Ruiz Oscar F Angiographic catheter with soft tip end
US4450841A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445896A (en) * 1982-03-18 1984-05-01 Cook, Inc. Catheter plug
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
US4573476A (en) * 1983-11-14 1986-03-04 Ruiz Oscar F Angiographic catheter
DE3419305A1 (en) * 1984-05-24 1985-11-28 Spiro Research B.V., Helmond METHOD AND DEVICE FOR REDUCING THE GAS CONTENT OF A LIQUID
US4674480A (en) * 1984-05-25 1987-06-23 Lemelson Jerome H Drug compositions and methods of applying same
US4610661A (en) * 1984-06-13 1986-09-09 Possis Medical, Incorporated Perfusion device
US5086620A (en) * 1991-02-14 1992-02-11 Wayne State University Method of microencapsulation of hyperbaric gas
US5407426A (en) * 1991-02-14 1995-04-18 Wayne State University Method and apparatus for delivering oxygen into blood
US5261875A (en) * 1991-02-14 1993-11-16 Wayne State University Method and apparatus for injection of gas hydrates
FR2574548B1 (en) * 1984-12-10 1987-07-31 Alsthom Atlantique DEVICE FOR MEASURING THE CONTENT OF A LIQUID IN CAVITATION GERM
US5158540A (en) * 1985-12-19 1992-10-27 Leocor, Inc. Perfusion catheter
DE3608943C1 (en) * 1986-03-18 1987-04-02 Christoph Dr Schmidt Tubular, flexible probe for insertion into the air ducts and bronchi
US4664680A (en) * 1986-04-07 1987-05-12 Atec Inc. Method and system for enriching oxygen content of water
US4834719A (en) * 1986-04-28 1989-05-30 Cordis Corporation Quick connect/disconnect tubing adapter
US4874509A (en) * 1987-04-24 1989-10-17 Donald Bullock Oxidation saturation device
GB8808330D0 (en) * 1988-04-08 1988-05-11 Unilever Plc Method of preparing chemical compound
US4973558A (en) * 1988-04-28 1990-11-27 Endotronics, Inc. Method of culturing cells using highly gas saturated media
US5116317A (en) * 1988-06-16 1992-05-26 Optimed Technologies, Inc. Angioplasty catheter with integral fiber optic assembly
GB8814477D0 (en) * 1988-06-17 1988-07-20 Unilever Plc Sublimation method
US4877031A (en) * 1988-07-22 1989-10-31 Advanced Cardiovascular Systems, Inc. Steerable perfusion dilatation catheter
US5021044A (en) * 1989-01-30 1991-06-04 Advanced Cardiovascular Systems, Inc. Catheter for even distribution of therapeutic fluids
US5114423A (en) * 1989-05-15 1992-05-19 Advanced Cardiovascular Systems, Inc. Dilatation catheter assembly with heated balloon
JP2501279Y2 (en) * 1989-06-19 1996-06-12 株式会社東海理化電機製作所 Connection device for catheter and injection tube
US5037403A (en) * 1989-11-08 1991-08-06 Cordis Corporation Pigtail catheter with angled apertures
US5209720A (en) * 1989-12-22 1993-05-11 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
US5084011A (en) * 1990-01-25 1992-01-28 Grady Daniel J Method for oxygen therapy using hyperbarically oxygenated liquid
US5137513A (en) * 1990-07-02 1992-08-11 Advanced Cardiovoascular Systems, Inc. Perfusion dilatation catheter
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5072739A (en) * 1991-06-05 1991-12-17 John Angelo P Ischemia-reperfusion tumor therapy
US5180364A (en) * 1991-07-03 1993-01-19 Robert Ginsburg Valved self-perfusing catheter guide
JPH09507391A (en) * 1991-07-24 1997-07-29 アドヴァンスト・カーディオヴァスキュラー・システムズ・インコーポレイテッド Low profile perfusion dilatation catheter
US5413558A (en) * 1991-09-09 1995-05-09 New York University Selective aortic perfusion system for use during CPR
US5334142A (en) * 1991-09-09 1994-08-02 New York University Selective aortic perfusion system
US5226888A (en) * 1991-10-25 1993-07-13 Michelle Arney Coiled, perfusion balloon catheter
US5273052A (en) * 1992-01-08 1993-12-28 Danforth Biomedical, Incorporated Guidewire with reversible contact seal for releasable securement to catheter
US5195971A (en) * 1992-02-10 1993-03-23 Advanced Cardiovascular Systems, Inc. Perfusion type dilatation catheter
US5356388A (en) * 1992-09-22 1994-10-18 Target Therapeutics, Inc. Perfusion catheter system
US5383853A (en) * 1992-11-12 1995-01-24 Medtronic, Inc. Rapid exchange catheter
US5437633A (en) * 1994-03-30 1995-08-01 The University Of North Carolina At Chapel Hill Selective aortic arch perfusion

Also Published As

Publication number Publication date
ES2184804T3 (en) 2003-04-16
US5569180A (en) 1996-10-29
DE69528766T2 (en) 2003-08-21
JPH10507400A (en) 1998-07-21
AU685651B2 (en) 1998-01-22
US5735934A (en) 1998-04-07
WO1996001593A1 (en) 1996-01-25
EP0767632B1 (en) 2002-11-06
EP0767632A1 (en) 1997-04-16
EP0767632A4 (en) 1998-12-09
DE69528766D1 (en) 2002-12-12
AU2948695A (en) 1996-02-09
JP3712729B2 (en) 2005-11-02
ATE227107T1 (en) 2002-11-15

Similar Documents

Publication Publication Date Title
CA2194961A1 (en) Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof
US6197279B1 (en) Methods of delivering oxygen with emulsions
EP0729369B1 (en) Method and apparatus for delivering oxygen
US6315942B1 (en) System for delivery of gas-enriched fluids
EP0571513B1 (en) Method of microencapsulation of hyperbaric gas
US5885467A (en) Method and apparatus for making oxygen enriched liquids
US5599296A (en) Apparatus and method of delivery of gas-supersaturated liquids
US7288574B2 (en) Two-phase oxygenated solution and method of use
EP1220695B1 (en) Apparatus for blood oxygenation
CA2286653A1 (en) System and method for delivery of gas-supersaturated fluids

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20030626